生命科学领域引来“东升西落”:美国医药业低迷,中国崛起

财经实验室TheF...
Nov 08

Pfizer、Gilead Sciences、GE HealthCare及Illumina均报告销售或利润下滑,S&P 500医疗类股一年内微跌1%,而指数整体上涨19%。Pfizer不仅面临营收下降,还与丹麦竞争对手Novo Nordisk竞购抗肥胖药企Metsera,出价从70亿美元上调至100亿美元。投资者对行业信心不足,Moderna成为被做空最多的个股。高关税、专利到期、研发回报下降及...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10